We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$67.5M
Cap. Flow
-$16.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
43.59%
Holding
2,793
New
103
Increased
1,023
Reduced
644
Closed
145

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 13.81%
3 Healthcare 6.79%
4 Consumer Discretionary 3.87%
5 Communication Services 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGT icon
2201
Allegiant Air
ALGT
$2.57B
$2.26K ﹤0.01%
30
KURA icon
2202
Kura Oncology
KURA
$850M
$2.24K ﹤0.01%
105
+23
+28% +$447
GLNG icon
2203
Golar LNG
GLNG
$5.13B
$2.24K ﹤0.01%
93
WS icon
2204
Worthington Steel
WS
$1.95B
$2.22K ﹤0.01%
62
MGRC icon
2205
McGrath RentCorp
MGRC
$2.92B
$2.22K ﹤0.01%
18
SHO icon
2206
Sunstone Hotel Investors
SHO
$2.06B
$2.22K ﹤0.01%
199
TMP icon
2207
Tompkins Financial
TMP
$1.42B
$2.21K ﹤0.01%
44
-50
-53% -$2.54K
GDEN
2208
DELISTED
Golden Entertainment
GDEN
$2.21K ﹤0.01%
60
-5
-8% -$185
OSG
2209
DELISTED
Overseas Shipholding Group Inc.
OSG
$2.21K ﹤0.01%
+345
New +$2.06K
MYGN icon
2210
Myriad Genetics
MYGN
$312M
$2.2K ﹤0.01%
103
NOVA
2211
DELISTED
Sunnova Energy
NOVA
$2.19K ﹤0.01%
357
-429
-55% -$3.87K
MRNS
2212
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2.19K ﹤0.01%
242
OPRA
2213
Opera Ltd
OPRA
$1.79B
$2.18K ﹤0.01%
+138
New +$1.74K
SMMT icon
2214
Summit Therapeutics
SMMT
$11.1B
$2.18K ﹤0.01%
527
CRSP icon
2215
CRISPR Therapeutics
CRSP
$5.17B
$2.18K ﹤0.01%
32
QNST icon
2216
QuinStreet
QNST
$1.21B
$2.17K ﹤0.01%
123
FDMT icon
2217
4D Molecular Therapeutics
FDMT
$562M
$2.17K ﹤0.01%
68
EAF icon
2218
GrafTech
EAF
$212M
$2.14K ﹤0.01%
155
-24
-13% -$374
ADNT icon
2219
Adient
ADNT
$1.5B
$2.14K ﹤0.01%
65
-6
-8% -$204
PFS icon
2220
Provident Financial Services
PFS
$3.19B
$2.13K ﹤0.01%
146
-436
-75% -$6.93K
HY icon
2221
Hyster-Yale Materials Handling
HY
$665M
$2.12K ﹤0.01%
33
+1
+3% +$64
DIOD icon
2222
Diodes
DIOD
$4.84B
$2.12K ﹤0.01%
30
-15
-33% -$1.04K
VSAT icon
2223
Viasat
VSAT
$11.1B
$2.1K ﹤0.01%
116
-160
-58% -$3.36K
MYE icon
2224
Myers Industries
MYE
$1.29B
$2.08K ﹤0.01%
90
SEMR
2225
DELISTED
Semrush
SEMR
$2.08K ﹤0.01%
157

Similar funds

Lindbrook Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Lindbrook Capital held 2,793 positions worth $1.07B, up 6.7% from $1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Lindbrook Capital's Q1 2024 filing shows 103 new, 1,023 increased, 644 reduced and 145 closed positions. Its largest new stake was Hess Midstream: 14,335 shares worth $518K. The largest sale was Golub Capital BDC, an estimated $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q1 2024 buy was Hess Midstream: 14,335 shares worth $518K.
  • Lindbrook Capital added most to Vertex Pharmaceuticals in Q1 2024, an estimated $8.03M increase.
  • Lindbrook Capital's biggest Q1 2024 reduction was Golub Capital BDC, cutting an estimated $15.8M.
  • Lindbrook Capital fully exited Splunk Inc in Q1 2024, selling an estimated $153K.
  • Lindbrook Capital's ten largest holdings make up 44% of its $1.07B portfolio in Q1 2024.
  • Lindbrook Capital opened 103 new positions and closed 145 in Q1 2024.
  • Lindbrook Capital's portfolio value rose 6.7% quarter-over-quarter to $1.07B.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.